Veeda Clinical Research is one of the largest independent full service clinical research organizations in India. With over 16years of experience, the company has partnered with members of the pharmaceutical fraternity globally, to deliver efficacious clinical research solutions. The company offers a broad range of services across most aspects of the drug development and drug launch value chain throughout the global markets including North America, Europe and Asia.
The fresh issue will comprise of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by the promoters and existing shareholders. Investors participating in the OFS include CX Alternative Investment Fund for up to Rs 8.08 crore, Arabelle Financial Services Limited for Rs 90.19 crore, Bondway Investment Inc. for Rs 259.77 crore, Stevey International Corporation for Rs 0.04 crore and Basil Private Limited for Rs 141.93 crore.
The company intends to utilise the net proceeds from the fresh issue
Listing at NSE, BSE
|IPO Open Date||To be announced|
|IPO Close Date||To be announced|
|Allotment Date||To be announced|
|Initiation Of Refunds||To be announced|
|Credit Of Shares To
|To be announced|
|IPO Listing Date||To be announced|
|UPI Mandate Expiry Date||To be announced|
|Particulars (in Rs. Crores)||2021||2020||2019|
|EPS (basic in Rs.)||15.39||-0.01||12.17|
|Cash generated from operating activities||7.66||0.91||8.20|
|Net cash from investing activities||-9.26||-0.90||-0.93|
|Net cash flow from financing activities||1.71||-0.34||-6.14|
|Net increase in cash and cash equivalents||0.11||-0.33||1.13|
A simple and smartest way to apply in IPO online via Religare Dynami Mobile App
Below are your top reasons:
Ongoing investments to provide technology driven CRO solutions and enhance operating efficiencies and compliance management
Increased focus on pre-clinical services to facilitate innovator drug development and discovery
Extensive scientific competence to service a global clientele ensuring high customer centricity and satisfaction
Failure to perform their services in accordance with contractual requirements, regulatory standards and ethical considerations could subject the company to significant costs and liability and harm to the reputation
Recently forayed into pre-clinical research with acquisition of Bioneeds and may be unable to fully realise the anticipated benefits of the acquisition or integrate the acquired expertise within expected timeframe or experience delays
The relationship of backlog to revenues varies over time and may not be fully realisable in the event of contract cancellation
Retail investors need to apply for the IPO using UPI
Fill up your personal details in the form above
Fill up your DOB, PAN, email & bank account details
Upload your photo and e-sign your application via Aadhaar OTP
Veeda Clinical Research Limited IPO consists of The fresh issue will comprise of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by the promoters and existing shareholders.
A lot size is the minimum number of shares that an investor has to bid for. A lot size differs for each IPO and is fixed by the company.
IPO Price Band is the price range within which investors can bid for the shares. The minimum price is called the floor price and the maximum price is called the cap price.
Issue size is the total value of an IPO. It is calculated by multiplying the number of shares offered by the company by the issue price per share.
You will receive an email on your registered email id if the IPO shares are allotted to you. Alternatively, you can also visit the registrar of the company’s official website and provide the details as asked in the allotment status section of the website.
IPOs, as such, do not have any taxes. You are taxed only when you decide to sell the IPO shares. Any monetary profit you make while selling the IPO shares is referred to as ‘capital gains’.
Capital gains tax is charged depending on how long you held the shares for. If you owned the shares for less than 12 months, it is considered as short-term capital gains and if it is over 12 months, it is referred as long-term capital gains.
Tax on short-term capital gains is 15%. It is 10% for equity gains in the long run (over 12 months). Do remember that you are taxed if the equity proceeds exceed Rs 1 lakh.